Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| musculoskeletal system disease | DOID_17 | [A disease of anatomical entity that occurs in the muscular and/or skeletal system.] |
| PathHunter CHO-K1 DRD2L Beta-Arrestin cell | CLO_0037265 | |
| RAW-Blue cell | CLO_0037268 | |
| acute stress disorder | DOID_6088 | [An anxiety disorder that has_symptom flashbacks, has_symptom bad dreams, has_symptom frightening thoughts, has_symptom avoidance or has_symptom hyperarousal of PTSD occurring within one month of a traumatic experience as Acute Stress Disorder or ASD.] |
| reproductive system disease | DOID_15 | [A disease of anatomical entity that is located_in reproductive system organs.] |
| LEADING LIGHT Wnt Reporter cell line cell | CLO_0037262 | |
| MG213 cell | CLO_0037264 | |
| MCL-1 1780 cell | CLO_0037263 | |
| EC 1.18.* (oxidoreductase acting on Fe-S proteins as donors) inhibitor | CHEBI_76745 | |
| EC 1.17.* (oxidoreductase acting on CH or CH2) inhibitor | CHEBI_76744 | |
| platelet-activating factor receptor agonist | CHEBI_75414 | |
| EC 1.20.* (oxidoreductase acting on P or As in donors) inhibitor | CHEBI_76747 | |
| EC 1.19.* (oxidoreductase acting on reduced flavodoxin as donor) inhibitor | CHEBI_76746 | |
| EC 1.21.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond) inhibitor | CHEBI_76748 | |
| S16 cell | CLO_0037269 | |
| EC 1.22* (oxidoreductase acting on halogen in donors) inhibitor | CHEBI_76750 | |
| EC 1.23.* (oxidoreductase acting on C-O-C group as acceptor) inhibitor | CHEBI_76752 | |
| neuron projection regeneration | GO_0031102 | [The regrowth of neuronal processes such as axons or dendrites in response to their loss or damage.] |
| regeneration | GO_0031099 | [The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass).] |
| EC 1.97.* (other oxidoreductase) inhibitor | CHEBI_76753 |